<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is one of the most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in the world </plain></SENT>
<SENT sid="1" pm="."><plain>In our work changes of AKR1B1 and AKR1B10 gene expression levels in <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> were studied </plain></SENT>
<SENT sid="2" pm="."><plain>Their potential diagnostic value was previously shown for several other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types </plain></SENT>
<SENT sid="3" pm="."><plain>These genes encode aldoso reductases, which belong to the aldo-keto reductases superfamily consisting of enzymes capable to reduce numerous aromatic and aliphatic <z:chebi fb="5" ids="17478">aldehydes</z:chebi> and <z:chebi fb="3" ids="17087">ketones</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>They are also involved into <z:chebi fb="0" ids="26537">retinoid</z:chebi> metabolism and cancerogenesis </plain></SENT>
<SENT sid="5" pm="."><plain>We have carried out comparative analysis of <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels of AKR1B1 and AKR1B10 genes in paired samples of <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> tissues using RT-PCR and quantitative PCR </plain></SENT>
<SENT sid="6" pm="."><plain>We have shown for the first time the decrease of activity of these genes in colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Significant reduction of AKR1B10 <z:chebi fb="2" ids="33699">mRNA</z:chebi> level was detected in the most of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples (88%, 65/74) even at the early stages of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, and in more than 60% of cases this downregulation was much higher than 10 folds </plain></SENT>
<SENT sid="8" pm="."><plain>The decrease of AKR1B1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> level was shown in 10% of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> only </plain></SENT>
<SENT sid="9" pm="."><plain>Therefore, we have detected quite different <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression patterns in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> for these two structurally similar genes </plain></SENT>
<SENT sid="10" pm="."><plain>These data could indicate different functional roles of these two genes in colorectum </plain></SENT>
<SENT sid="11" pm="."><plain>The significant decrease of AKR1B10 <z:chebi fb="2" ids="33699">mRNA</z:chebi> in most samples of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> could be considered as potential diagnostic marker of this type of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>